CABOZANTINIB

CABOZANTINIB TABLETS 20 / 80 MG

Indication

For the treatment of patients with advanced renal cell carcinoma (RCC). For the treatment of patients with Hepatocellular Carcinoma (HCC) who have been previously treated with sorafenib.

Pack

30 Tablets
Categories: ,

Note: Products are not marketed in countries where it is protected by Patent Law